The Fall Meeting of the KSLM was expanded to become an international conference from this year and is the first international scientific meeting in the field of laboratory medicine in the Asian region.
About 1,000 in-vitro diagnosis experts from 27 countries including not only Asian countries (Japan, China, Taiwan, Indonesia, etc.) but also the U.S., Australia, France, and the UK participated in this event.

?

At this year’s congress, Seegene held a luncheon workshop on the results of the evaluation of its Allplex™ Respiratory Panel 1, which recently received licensing from the Ministry of Food and Drug Safety (MFDS) as an in-vitro diagnosis product, as well as Panels 2 and 3, which are in the process of receiving the MFDS marks as well. During the education workshop, one of the programs of the congress, Professor Sung Heungsup of the Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center gave a presentation on the results of the clinical evaluation of Seegene’s Allplex™ Respiratory Panel assays as well as their effectiveness in diagnosing the symptoms of acute respiratory diseases, attracting significant attention from experts in related fields.

?

The Allplex™ Respiratory Panel 1 uses the Multiplex PCR method to rapidly distinguish and test for influenza A/B viruses and RSV A/B while simultaneously testing for subtypes of the influenza A virus. This enables doctors to prescribe the most appropriate anti-viral treatment for each infection.

?

Panels 2, 3, and 4, which test for respiratory viruses and bacteria other than influenza and RSV, received CE certification in 2015 and are currently being supplied to general hospitals and screening centers in Europe. In South Korea, they are in the final stages of the licensing process and will soon be ready for release in the domestic market.